Hepatitis delta virus (HDV) infection sometimes causes severe and fulminant hepatitis as a coinfection or superinfection along with the hepatitis B virus. To elucidate the underlying mechanism of injury caused by HDV, we examined whether two isoforms of the hepatitis delta antigen (HDAg) had any effect on five well-defined intracellular signal transduction pathways: serum response factor (SRF)-, serum response element (SRE)-, nuclear factor κB-, activator protein 1-, and cyclic AMP response element-dependent pathways.
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INTRODUCTION
Hepatitis delta antigen (HDAg) was discovered as an antigen localized in the nuclei of hepatocytes in a patient who had already been infected with the hepatitis B virus (HBV) (1) . HDAg is the only known protein encoded by the hepatitis delta virus (HDV), which is a defective human pathogen whose transmission requires the helper function of HBV (2) . The two isoforms of HDAg, large and small forms (3, 4) , are identical except for additional 19 residues located at the C-terminus of the large form. The small form of HDAg (SHDAg) consists of 195 amino acids (aa) (molecular weights; 24 kDa), and the large form of HDAg (LHDAg) consists of 214 aa (27 kDa) (5, 6) . Both forms of HDAgs have common functional domains: an N-terminal coiled-coil domain responsible for oligomerization (7) , a central domain responsible for a nuclear localization signal (8, 9) , and a central helix-turn-helix domain responsible for binding to the RNA genome (10, 11) . Despite these structural similarities, the two HDAgs play complementary roles in HDV replication; SHDAg is required for genome replication (12) , but LHDAg acts as an inhibitor of replication (13) . LHDAg is also required for HDV assembly (14, 15) ; the formation of HDV viral particles requires isoprenylation at the C-terminus of the LHDAg (16) , although the mechanism of LHDAg on this packaging remains unclarified.
It has been shown that SHDAg suppresses the gene expression of HBV (17) .
Nevertheless, HDV infection often causes severe chronic hepatitis and liver cirrhosis as a superinfection of chronic HBV carriers and fulminant hepatitis as a coinfection with HBV (18) . It was also reported that SHDAg possessed a cytotoxic effect on infected hepatocytes, while LHDAg was thought to reduce this 
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EXPERIMENTAL PROCEDURES
Construction of HDAgs expressing plasmids
The HDV sequence used in this study was derived from pSVLD3 (kindly provided by Dr. J. Taylor, Fox Chase Cancer Center, PA), containing a trimer of unit-length HDV cDNA (12, 20) . Both LHDAg and SHDAg regions were amplified by polymerase chain reaction using the following primers having a ScaI All cloned plasmids were purified using the Endofree plasmid kit (Qiagen, Hilden, Germany) and sequenced using an autosequencer (PE Applied Biosystems, Foster City, CA) by the dye-termination method as described previously (23) to confirm the integration of HDAg genes.
Construction of Elk1-and SRF-expressing plasmids
Using the T7Elk 1-428 (kindly provided by Dr. R. Treisman, Imperial
Cancer Research Fund, UK) (24) as a template, the full-length Elk1 region (1-428 aa) was amplified by polymerase chain reaction with Elk1 region-specific primers having an XhoI restriction site. Amplified products were digested with XhoI and then cloned into the XhoI site of pCXN2 to generate pCXN2-Elk1.
pFA-GALElk (Stratagene) expresses the activation domain of Elk1 (307-427 aa) fused to the GAL4 DNA-BD. A plasmid expressing SRF (10-508 aa) fused to the GAL4 DNA-BD, pSG5-GALSRF (10-508), was a gift from Dr. M.
Fujii (Kanazawa University, Japan) (25) . (27) , were utilized. Specific mutations were introduced into the SM22α-Luc and HF456 plasmids using site-directed mutagenesis (Stratagene). The specific base changes were chosen based on their ability to disrupt SRF binding. As for the SM22α-Luc, the CArG box 1 at bp -162 to bp -153 was converted from CCAAATATGG to AAAAATATGG (SM22α m1-Luc); the CArG box 2 at bp -283 to bp -266 was converted from CCATAAAAGGTTTTTCCC to CCATAAAAAATTTTTCCC (SM22α m2-Luc).
Reporter plasmids of intracellular signal transduction pathways
Combinations of mutations were generated by performing mutagenesis reactions on a template already containing a mutation (SM22α m1m2-Luc). As for the HF456, the CArG box at bp -314 to bp -305 was converted from CCATATTAGG Forty-eight hours after transfection, whole cell lysates were examined for luciferase activity (PicaGene dual Sea Pansy system, Toyo ink, Tokyo, Japan) with a luminometer (Lumat LB9507, EG&G Berthold, Bad Wildbad, Germany).
Firefly-luciferase activity was normalized for transfection efficiency based on Seapansy-luciferase activity. The luciferase activity of the cells which were transfected with the reporter plasmid plus pCXN2 was set arbitrarily at 1.0, and then the relative luciferase activity was compared to this established value. Assays were performed at least in triplicate.
Concentration of cells transiently transfected with plasmids
As only a small percentage of the cells were transfected by a transient transfection method, we utilized the MACSelect system (Miltenyi Biotec, 
Western blotting analysis
LHDAg and SHDAg expression was confirmed by Western blotting (ECLplus, Amersham, Buckinghamshire, UK) using the soluble protein extracts of HeLa cells which were transfected with pCXN2, pCXN2-DL, or pCXN2-DS (31).
HDAg expression was examined using serum obtained from a patient with 
12
RESULTS
Activation of SRF-and SRE-dependent signal transduction pathways by LHDAg
Each of the five reporter plasmids (pSRF-Luc, pSRE-Luc, pNF-κB-Luc, pAP1-Luc, or pCRE-Luc) was transiently cotransfected into HeLa cells with pCXN2, pCXN2-DL, or pCXN2-DS. LHDAg activated the SRF-and SREdependent signal transduction pathway at a value 4.0 + 1.2 (mean + SD)-fold and 2.5 + 1.0-fold higher than the control, respectively (Fig. 1A) . There was no significantly increased activation in the remaining three pathways by LHDAg. In addition, SHDAg did not activate any of the five pathways (Fig. 1A) . Expression of LHDAg and SHDAg were confirmed by Western blotting at the expected size:
LHDAg at a molecular weight of 27 kDa, and SHDAg at a molecular weight of 24 kDa (5).
Cell line independent and dose-dependent activation of SRF-dependent pathway by LHDAg
We investigated whether LHDAg activated the SRF-dependent pathway in other cell lines. Results similar to those in HeLa cells were obtained in HuH-7 cells (4.3 + 2.4-fold higher than control) and HepG2 cells (3.3 + 1.0-fold) (Fig.   1B ). In addition, LHDAg activated the SRF-dependent signal in a dose-dependent manner in HeLa cells (Fig. 1C) . (Fig. 2) .
Enhancement of transcriptional ability of SRF by LHDAg
Because LHDAg is a nuclear protein, we examined whether LHDAg itself 
LHDAg activates the SRE-dependent pathway through SRF, not Elk1
LHDAg activated not only the SRF-dependent pathway but also the SRE- Western blotting, and 3) the human c-fos promoter containing SRE.
Transcriptional activation and phosphorylation of Elk1 protein: HeLa cells
were transiently transfected with pFR-Luc, pFA-GALElk, and pCXN2-DL. Cells were then assayed for luciferase activity. The transcriptional ability of ELK1 was not increased by LHDAg (Fig. 3C) . Western blotting analysis of Elk1 also indicated that LHDAg did not enhance the phosphorylation of Elk1 (Fig. 3C ), thereby suggesting that LHDAg has no effect on the transcriptional ability of Elk1.
The effect of HDAgs on a human c-fos promoter: by use of HF456, a reporter plasmid with a c-fos promoter containing SRE, the luciferase activity increased by a value 1.8 + 0.3-fold higher than the control with LHDAg (Fig. 4C) , while it did not increase with SHDAg (data not shown). To determine whether this activation by LHDAg was mediated by the CArG box, we mutated the CArG box and then measured luciferase activity with LHDAg or without LHDAg. Mutation of the CArG box was introduced into the indicated element in the context of the wild type reporter construct (Fig. 4A ) and the influence was examined. As shown in LHDAg, however, did not increase SRF binding to the CArG box, while PKA enhanced the binding (Fig. 3B) . Although the mechanism underlying activation of the SRF-dependent signaling pathway has not been completely elucidated, there is mention that PKA is required for SRF nuclear import (43) . PKA has also been shown to activate the CRE-dependent pathway. Therefore, this evidence together with a lack of activation of the CRE-dependent pathway by LHDAg (Fig.1A) leads to the conclusion that SRF activation by LHDAg seems to be PKAindependent. These results suggest that LHDAg activates SRF-associated transcription through a novel mechanism.
In the case of HBx, results similar to those of LHDAg have been noted (44) . In summary, LHDAg, but not SHDAg, activates SRF-associated pathways.
This observation may provide clues to help clarify the functional differences between LHDAg and SHDAg and the pathogenesis of delta hepatitis. 
